NSE:INDRAMEDCO (India)
Â
Shs Dematerialised
₹
479.90
(-0.68%)
Dec 13
Business Description
Indraprastha Medical Corp Ltd
ISIN : INE681B01017
Share Class Description:
NSE:INDRAMEDCO: Shs DematerialisedCompare
Compare
Traded in other countries / regions
532150.India IPO Date
1997-04-17Description
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.7 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.13 | |||||
| Interest Coverage | 70.43 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 12.51 | |||||
| Beneish M-Score | -3.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26.4 | |||||
| 3-Year EBITDA Growth Rate | 76.6 | |||||
| 3-Year EPS without NRI Growth Rate | 255.1 | |||||
| 3-Year FCF Growth Rate | 181.7 | |||||
| 3-Year Book Growth Rate | 20.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.64 | |||||
| 9-Day RSI | 53.49 | |||||
| 14-Day RSI | 56.76 | |||||
| 3-1 Month Momentum % | -13.68 | |||||
| 6-1 Month Momentum % | 65.18 | |||||
| 12-1 Month Momentum % | 122.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.07 | |||||
| Quick Ratio | 2.03 | |||||
| Cash Ratio | 1.56 | |||||
| Days Inventory | 3.42 | |||||
| Days Sales Outstanding | 19.22 | |||||
| Days Payable | 59.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.94 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| Forward Dividend Yield % | 0.94 | |||||
| 5-Year Yield-on-Cost % | 0.93 | |||||
| Shareholder Yield % | 0.25 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.1 | |||||
| Operating Margin % | 14.49 | |||||
| Net Margin % | 11.56 | |||||
| FCF Margin % | 10.23 | |||||
| ROE % | 31.29 | |||||
| ROA % | 20.18 | |||||
| ROIC % | 31.27 | |||||
| 3-Year ROIIC % | 90.59 | |||||
| ROC (Joel Greenblatt) % | 60.35 | |||||
| ROCE % | 37.26 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.82 | |||||
| PE Ratio without NRI | 30.64 | |||||
| Shiller PE Ratio | 75.92 | |||||
| Price-to-Owner-Earnings | 24.28 | |||||
| PEG Ratio | 1.2 | |||||
| PS Ratio | 3.57 | |||||
| PB Ratio | 8.68 | |||||
| Price-to-Tangible-Book | 8.4 | |||||
| Price-to-Free-Cash-Flow | 34.83 | |||||
| Price-to-Operating-Cash-Flow | 22.75 | |||||
| EV-to-EBIT | 19.96 | |||||
| EV-to-EBITDA | 16.48 | |||||
| EV-to-Revenue | 3.14 | |||||
| EV-to-FCF | 32.97 | |||||
| Price-to-GF-Value | 3.77 | |||||
| Price-to-Projected-FCF | 3.44 | |||||
| Price-to-Median-PS-Value | 5.02 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.18 | |||||
| Price-to-Graham-Number | 3.32 | |||||
| Price-to-Net-Current-Asset-Value | 31.93 | |||||
| Price-to-Net-Cash | 124.01 | |||||
| Earnings Yield (Greenblatt) % | 5.02 | |||||
| FCF Yield % | 3.03 | |||||
| Forward Rate of Return (Yacktman) % | 21.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Indraprastha Medical Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 12,782.3 | ||
| EPS (TTM) (₹) | 16.12 | ||
| Beta | 0.61 | ||
| 3-Year Sharpe Ratio | 1.14 | ||
| 3-Year Sortino Ratio | 3.27 | ||
| Volatility % | 77.67 | ||
| 14-Day RSI | 56.76 | ||
| 14-Day ATR (₹) | 20.906138 | ||
| 20-Day SMA (₹) | 460.945 | ||
| 12-1 Month Momentum % | 122.28 | ||
| 52-Week Range (₹) | 154.5 - 529.9 | ||
| Shares Outstanding (Mil) | 91.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Indraprastha Medical Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Indraprastha Medical Corp Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Indraprastha Medical Corp Ltd Frequently Asked Questions
What is Indraprastha Medical Corp Ltd(NSE:INDRAMEDCO)'s stock price today?
The current price of NSE:INDRAMEDCO is ₹479.90. The 52 week high of NSE:INDRAMEDCO is ₹529.90 and 52 week low is ₹154.50.
When is next earnings date of Indraprastha Medical Corp Ltd(NSE:INDRAMEDCO)?
The next earnings date of Indraprastha Medical Corp Ltd(NSE:INDRAMEDCO) is .
Does Indraprastha Medical Corp Ltd(NSE:INDRAMEDCO) pay dividends? If so, how much?
The Dividend Yield %  of Indraprastha Medical Corp Ltd(NSE:INDRAMEDCO) is 0.94% (As of Today), Highest Dividend Payout Ratio of Indraprastha Medical Corp Ltd(NSE:INDRAMEDCO) was 0.75. The lowest was 0.22. And the median was 0.48. The  Forward Dividend Yield % of Indraprastha Medical Corp Ltd(NSE:INDRAMEDCO) is 0.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers